Safety alerts
4 safety alerts appeared in Japan during Week 16, 2026. Safety concentration usually matters to quality, vigilance, and post-market surveillance teams because it can reveal emerging field risks.
Japan medical device regulatory intelligence, Week 16, 2026.
Signals from 2026-04-13 to 2026-04-19, covering safety alerts, regulatory changes, device registrations, market movement, and source activity for Japan.
Signals
6
Sources
3
Index status
Indexable
EXECUTIVE SUMMARY
Japan generated 6 qualifying medical device signals during Week 16, 2026. Safety alerts led the week with 4 signals, while FDA Device Enforcement was the most active source. Sonire Therapeutics raised $18 million to advance its high-intensity focused ultrasound system trial in Japan. LAI-PrEP testing strategies show similar HIV detection rates but RDTs offer faster results and lower costs.
Key observations
Safety alerts accounted for 4 of 6 qualifying signals, making it the main review lane for the week.
Competitor moves formed the second-largest cluster, which is useful context for teams separating safety work from regulatory and market monitoring.
FDA Device Enforcement contributed 4 signals, so source-level follow-up should start there.
Vinci appeared repeatedly in the highlighted signals, which may warrant closer product, manufacturer, or competitor tracking.
Category interpretation
Competitor moves
1 competitor moves appeared in Japan during Week 16, 2026. Competitor-linked activity is most useful when paired with product codes, indication context, and adjacent safety signals.
Market signals
1 market signals appeared in Japan during Week 16, 2026. Market signals help connect regulatory monitoring with launch planning, reimbursement, and commercial strategy.
Recommended monitoring focus
- Review PMDA safety and recall activity for product categories that overlap your portfolio.
- Review competitor-linked signals for launch timing, market access movement, and product category momentum.
- Use market trend signals to brief commercial, strategy, and market access teams alongside regulatory stakeholders.
Source-backed signal evidence
These source-linked items support the weekly analysis above. They are included for verification and follow-up, not as a raw feed export.
Medical Device Network·Competitor moves·
Sonire Therapeutics raises $18m for tumour ablation platform advancement
Sonire Therapeutics raised $18 million to advance its high-intensity focused ultrasound system trial in Japan.
SourcePLOS Medicine·Market signals·
Rapid diagnostic tests, laboratory-based immunoassay and nucleic acid testing strategies for long-acting injectable pre-exposure prophylaxis: A systematic review
LAI-PrEP testing strategies show similar HIV detection rates but RDTs offer faster results and lower costs.
SourceFDA Device Enforcement·Safety alerts·
Enforcement Class II: Brand Name: da Vinci S, Si Permanent Cautery Hook Instrument Product Name: da Vinci S, Si Permanent Cautery Hook Instrument Model/Catalog Number: 420183 Software Version: NA Product Description: E (Intuitive Surgical, Inc.)
Intuitive Surgical recalls da Vinci S, Si Cautery Hook due to frayed cables, affecting global distribution.
SourceFDA Device Enforcement·Safety alerts·
Enforcement Class II: Brand Name: da Vinci S, Si Grasping Retractor Instrument Product Name: da Vinci S, Si Grasping Retractor Instrument Model/Catalog Number: 420278 Software Version: NA Product Description: EndoWrist (Intuitive Surgical, Inc.)
The da Vinci S, Si Grasping Retractor Instrument is recalled due to complaints of broken grip cables.
SourceFDA Device Enforcement·Safety alerts·
Enforcement Class II: Allura Xper FD20/10; System Code: 722029; (PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.)
Philips recalls Allura Xper FD20/10 due to intermittent X-ray imaging issues with the wired foot switch.
SourceFDA Device Enforcement·Safety alerts·
Enforcement Class II: Brand Name: da Vinci S, Si Mega Needle Driver Instrument Product Name: da Vinci S, Si Mega Needle Driver Instrument Model/Catalog Number: 420194 Software Version: NA Product Description: EndoWrist (Intuitive Surgical, Inc.)
Intuitive Surgical recalls da Vinci S, Si Mega Needle Driver due to grip cable issues affecting safety.
SourceSafety alerts
FDA Device Enforcement·Safety alerts·
Enforcement Class II: Brand Name: da Vinci S, Si Permanent Cautery Hook Instrument Product Name: da Vinci S, Si Permanent Cautery Hook Instrument Model/Catalog Number: 420183 Software Version: NA Product Description: E (Intuitive Surgical, Inc.)
Intuitive Surgical recalls da Vinci S, Si Cautery Hook due to frayed cables, affecting global distribution.
SourceFDA Device Enforcement·Safety alerts·
Enforcement Class II: Brand Name: da Vinci S, Si Grasping Retractor Instrument Product Name: da Vinci S, Si Grasping Retractor Instrument Model/Catalog Number: 420278 Software Version: NA Product Description: EndoWrist (Intuitive Surgical, Inc.)
The da Vinci S, Si Grasping Retractor Instrument is recalled due to complaints of broken grip cables.
SourceFDA Device Enforcement·Safety alerts·
Enforcement Class II: Allura Xper FD20/10; System Code: 722029; (PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.)
Philips recalls Allura Xper FD20/10 due to intermittent X-ray imaging issues with the wired foot switch.
SourceFDA Device Enforcement·Safety alerts·
Enforcement Class II: Brand Name: da Vinci S, Si Mega Needle Driver Instrument Product Name: da Vinci S, Si Mega Needle Driver Instrument Model/Catalog Number: 420194 Software Version: NA Product Description: EndoWrist (Intuitive Surgical, Inc.)
Intuitive Surgical recalls da Vinci S, Si Mega Needle Driver due to grip cable issues affecting safety.
SourceCompetitor moves
Medical Device Network·Competitor moves·
Sonire Therapeutics raises $18m for tumour ablation platform advancement
Sonire Therapeutics raised $18 million to advance its high-intensity focused ultrasound system trial in Japan.
SourceMarket signals
PLOS Medicine·Market signals·
Rapid diagnostic tests, laboratory-based immunoassay and nucleic acid testing strategies for long-acting injectable pre-exposure prophylaxis: A systematic review
LAI-PrEP testing strategies show similar HIV detection rates but RDTs offer faster results and lower costs.
SourceTrack these signals continuously.
MedFlux monitors regulators and medical device market sources across priority countries so regulatory, quality, and strategy teams can review changes without manually checking agency databases.